0000000000018704

AUTHOR

Chiara Intrivici

showing 11 related works from this author

Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel (P) as second line chemotherapy in metastatic bladder cancer.

2008

bladder cancer Pegylated liposomal doxorubicin (PLD)weekly paclitaxel
researchProduct

Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.

2008

adrenocortical carcinoma chemotherapy
researchProduct

Antifungal prophylaxis of oropharyngeal mucositis with itraconazole during adjuvant chemotherapy in colorectal cancer (CRC)patients.

2008

itraconazole prophylaxis mucositis
researchProduct

The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final …

2010

bladder cancer
researchProduct

Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized…

2006

researchProduct

“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)”

2008

Settore MED/06 - Oncologia MedicaBREAST CANCERHER2/NEU
researchProduct

The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation.

2005

researchProduct

A case report of inflammatory pseudotumor of the liver

2006

researchProduct

Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer

2004

researchProduct

Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZI…

2004

researchProduct

La terapia adiuvante nel carcinoma del colon: un update della lettaratura

2004

researchProduct